A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update

COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based...

Full description

Saved in:
Bibliographic Details
Published inBMC infectious diseases Vol. 21; no. 1; pp. 906 - 7
Main Authors Mohammadi, Faezeh, Badri, Milad, Safari, Shapoor, Hemmat, Nima
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 03.09.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis. Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases.
AbstractList Abstract Background COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. Case presentation A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis. Conclusion Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases.
COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases.
Background COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. Case presentation A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis. Conclusion Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases.
COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis. Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases.
COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids.BACKGROUNDCOVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids.A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis.CASE PRESENTATIONA 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis.Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases.CONCLUSIONOur report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases.
Background COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial mucormycosis during treatment with corticosteroids. Case presentation A 59-year-old non-diabetic male patient was admitted with a diagnosis of COVID-19 based on positive RT-PCR and CT of the lungs. Due to sever lung involvement, he was treated with methylprednisolone. The patient was re-admitted to hospital, due to nasal obstruction and left side facial and orbital swelling, several days after discharge. In sinus endoscopic surgery, debridement was performed and the specimens were sent to pathology and mycology laboratories. A nasal biopsy showed wide hyphae without septa. The sequenced PCR product revealed Rhizopus oryzae. Despite all medical and surgical treatment, the patient died. In addition, the characteristics of patients with COVID-19-associated mucormycosis were reviewed in 44 available literatures. In most studies, diabetes mellitus was the most common predisposing factor for mucormycosis. Conclusion Our report highlights the need for assessing the presence of mucormycosis in patients with COVID-19 and also it shows that physicians should consider the potential for secondary invasive fungal infections in COVID-19 cases. Keywords: COVID-19, Mucormycosis, Rhizopus oryzae
ArticleNumber 906
Audience Academic
Author Hemmat, Nima
Safari, Shapoor
Mohammadi, Faezeh
Badri, Milad
Author_xml – sequence: 1
  givenname: Faezeh
  orcidid: 0000-0002-9822-2626
  surname: Mohammadi
  fullname: Mohammadi, Faezeh
– sequence: 2
  givenname: Milad
  orcidid: 0000-0002-1860-326X
  surname: Badri
  fullname: Badri, Milad
– sequence: 3
  givenname: Shapoor
  surname: Safari
  fullname: Safari, Shapoor
– sequence: 4
  givenname: Nima
  surname: Hemmat
  fullname: Hemmat, Nima
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34479495$$D View this record in MEDLINE/PubMed
BookMark eNqNk9tu1DAQhiNURA_wAlwgS9zARUp8ShwukKpyWqnSShx6a02cydZVEi-209I34LFxui3arRBCvrBlf_8_9njmMNsb3YhZ9pwWx5Sq8k2gTFV1XjCaF2XJZM4fZQdUVDRnnIu9rfV-dhjCZVHQSrH6SbbPhahqUcuD7NcJMRCQeFw7H4nriL-wo8s7MBZ6MkzG-eHGuGADsSMBku6QtxYajNaQNUSLYyTXNl6Q0-X54n1O67eJCjch4gAz4_HK4vXs3NuIHuLkkcDYEjN5P4undQsRn2aPO-gDPrubj7LvHz98O_2cny0_LU5PznJTchpz03SoUJmmLVvRSENlYzpoK15BUzFKjQHKqo4LWSB2KMv5nJUAShSSIeNH2WLj2zq41GtvB_A32oHVtxvOrzT4dO8edQqAtO7qVolSKMkVFKwSKKkqGlUwTF7vNl7rqRmwNek1Hvod092T0V7olbvSSlBZ1jIZvLoz8O7HhCHqwQaDfQ8juiloliiuGC9pQl8-QC_d5MeUqkRV6T9prbaoFaQH2LFzKa6ZTfVJWUnGGZUiUcd_odJocbAmFVln0_6O4PWOIDERf8YVTCHoxdcv_88uz3fZF9sJ_JO5-_pMgNoAxrsQPHba2JjKys35tL2mhZ5bQW9aQadW0LetoHmSsgfSe_d_iH4Dqz0JiQ
CitedBy_id crossref_primary_10_1371_journal_pone_0271333
crossref_primary_10_1016_j_mehy_2021_110748
crossref_primary_10_1016_j_identj_2022_02_010
crossref_primary_10_1007_s00774_022_01330_w
crossref_primary_10_1007_s40278_022_13796_7
crossref_primary_10_1159_000536370
crossref_primary_10_1080_01676830_2023_2186435
crossref_primary_10_1007_s11033_021_07085_3
crossref_primary_10_1007_s15010_023_02147_z
crossref_primary_10_1016_j_radcr_2022_05_049
crossref_primary_10_3390_jof8070756
crossref_primary_10_4103_jfmpc_jfmpc_2401_21
crossref_primary_10_4103_jmau_jmau_81_23
crossref_primary_10_1007_s00284_023_03430_w
crossref_primary_10_7759_cureus_24986
crossref_primary_10_29333_ejmds_11973
crossref_primary_10_36106_gjra_4202353
crossref_primary_10_1055_s_0042_1751003
crossref_primary_10_4103_ijpm_ijpm_792_22
crossref_primary_10_4103_jomfp_jomfp_236_24
Cites_doi 10.4103/ijo.IJO_1053_21
10.1017/S0022215121000992
10.1111/tid.13652
10.1007/s11908-012-0272-6
10.18203/issn.2454-5929.ijohns20211583
10.3389/fmed.2021.645270
10.21203/rs.3.rs-533347/v1
10.2807/1560-7917.ES.2021.26.23.2100510
10.4103/ijo.IJO_3763_20
10.1016/j.idcr.2021.e01172
10.3390/jof7020088
10.1002/alr.22785
10.1016/S1473-3099(19)30312-3
10.1016/j.mycmed.2021.101125
10.1007/s12281-019-0337-1
10.1016/j.neurad.2021.05.007
10.1016/j.idnow.2021.01.010
10.1016/j.diabet.2012.01.002
10.1016/j.ijmmb.2021.05.009
10.1111/myc.13256
10.4103/ijo.IJO_3774_20
10.1016/j.radcr.2020.09.026
10.3390/jof6040265
10.22551/2020.28.0703.10172
10.1016/j.ijscr.2021.105957
10.21203/rs.3.rs-398594/v2
10.1016/S2666-5247(20)30115-4
10.1111/myc.13334
10.1016/S0030-6665(00)80010-9
10.5694/mja2.50674
10.14740/jmc3637
10.1016/j.cmi.2020.09.025
10.1016/j.ajem.2021.01.074
10.1136/bcr-2021-241663
10.1016/j.cmi.2019.11.021
10.1097/IOP.0000000000001889
10.1177/11206721211009450
10.1067/mhn.2002.126587
10.1016/j.cmi.2020.07.047
10.1093/cid/cir866
10.3390/jof7030174
10.5946/ce.2020.180
10.1007/s12070-021-02574-0
10.1111/tid.13663
ContentType Journal Article
Copyright 2021. The Author(s).
COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: 2021. The Author(s).
– notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QL
7T2
7U9
7X7
7XB
88E
8C1
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
C1K
CCPQU
COVID
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
M7N
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12879-021-06625-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Opposing Viewpoints (Gale in Context)
Gale In Context: Science
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Health and Safety Science Abstracts (Full archive)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Sustainability
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database
MEDLINE
MEDLINE - Academic



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2334
EndPage 7
ExternalDocumentID oai_doaj_org_article_d4be19f9d84648538a0274e5180b802e
PMC8415695
A675232154
34479495
10_1186_s12879_021_06625_3
Genre Systematic Review
Journal Article
Case Reports
GeographicLocations Iran
United Kingdom--UK
GeographicLocations_xml – name: Iran
– name: United Kingdom--UK
GrantInformation_xml – fundername: Qazvin University of Medical Sciences
  grantid: IR.QUMS.REC.1399.357
– fundername: ;
  grantid: IR.QUMS.REC.1399.357
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8C1
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
IOV
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7QL
7T2
7U9
7XB
8FK
AZQEC
C1K
COVID
DWQXO
H94
K9.
M7N
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c631t-cbfe8e8cbd6d4b5c15bcfad737ab7211cca127f3450eefe565bcf26aa84052e23
IEDL.DBID M48
ISSN 1471-2334
IngestDate Wed Aug 27 01:29:31 EDT 2025
Thu Aug 21 18:30:57 EDT 2025
Tue Aug 05 11:09:52 EDT 2025
Fri Jul 25 06:07:53 EDT 2025
Tue Jun 17 21:03:15 EDT 2025
Tue Jun 10 20:49:26 EDT 2025
Fri Jun 27 04:09:20 EDT 2025
Fri Jun 27 04:18:44 EDT 2025
Thu Jan 02 22:39:47 EST 2025
Thu Apr 24 23:00:10 EDT 2025
Tue Jul 01 01:57:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19
Mucormycosis
Rhizopus oryzae
Language English
License 2021. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c631t-cbfe8e8cbd6d4b5c15bcfad737ab7211cca127f3450eefe565bcf26aa84052e23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Report-3
ObjectType-Case Study-4
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Undefined-5
ObjectType-Report-1
ObjectType-Article-3
ORCID 0000-0002-9822-2626
0000-0002-1860-326X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12879-021-06625-3
PMID 34479495
PQID 2574471981
PQPubID 42582
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_d4be19f9d84648538a0274e5180b802e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8415695
proquest_miscellaneous_2569382361
proquest_journals_2574471981
gale_infotracmisc_A675232154
gale_infotracacademiconefile_A675232154
gale_incontextgauss_ISR_A675232154
gale_incontextgauss_IOV_A675232154
pubmed_primary_34479495
crossref_citationtrail_10_1186_s12879_021_06625_3
crossref_primary_10_1186_s12879_021_06625_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-09-03
PublicationDateYYYYMMDD 2021-09-03
PublicationDate_xml – month: 09
  year: 2021
  text: 2021-09-03
  day: 03
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC infectious diseases
PublicationTitleAlternate BMC Infect Dis
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References YP Talmi (6625_CR8) 2002; 127
6625_CR28
6625_CR27
6625_CR29
LO Dallalzadeh (6625_CR35) 2021; 1
F Mohammadi (6625_CR6) 2018; 47
M Sen (6625_CR15) 2021; 69
A Khatri (6625_CR42) 2021; 187
S Sarkar (6625_CR16) 2021; 69
D Pasero (6625_CR52) 2020; 16
S Mehta (6625_CR12) 2020; 12
A Patel (6625_CR58) 2020; 26
A Moorthy (6625_CR14) 2021; 73
6625_CR20
OA Cornely (6625_CR5) 2019; 19
C Zurl (6625_CR49) 2021; 7
6625_CR25
C Arana (6625_CR47) 2021; 89
MN Gamaletsou (6625_CR4) 2012; 14
B Rammaert (6625_CR54) 2012; 38
S Sharma (6625_CR17) 2021; 135
DA Placik (6625_CR37) 2020; 15
L Szarpak (6625_CR2) 2021
S Challa (6625_CR10) 2019; 13
N Bayram (6625_CR32) 2021; 1
HA Farid (6625_CR53) 2021; 6
6625_CR50
BJ Ferguson (6625_CR9) 2000; 33
PG Gibson (6625_CR1) 2020; 213
R Rao (6625_CR23) 2021; 69
HS Meshram (6625_CR24) 2021; 2021
6625_CR55
TM Rawson (6625_CR56) 2021; 27
6625_CR57
A Werthman-Ehrenreich (6625_CR36) 2021; 42
B Hanley (6625_CR46) 2020; 1
do Monte Junior ES (6625_CR48) 2020; 53
V Krishna (6625_CR45) 2021; 23
S Waizel-Haiat (6625_CR51) 2021; 13
G Petrikkos (6625_CR7) 2012; 54
A Skiada (6625_CR11) 2020; 6
N Mishra (6625_CR19) 2021; 7
K Alekseyev (6625_CR39) 2021; 12
MM Ashour (6625_CR33) 2021
SM Revannavar (6625_CR18) 2021; 14
AK Johnson (6625_CR40) 2021; 32
M Helleberg (6625_CR3) 2021; 27
YA Fouad (6625_CR34) 2021; 8
A Kanwar (6625_CR41) 2021; 7
FAM Sargin (6625_CR31) 2021; 12
A Maini (6625_CR21) 2021; 82
ZK Mekonnen (6625_CR38) 2021; 37
N Khan (6625_CR43) 2020; 7
D Garg (6625_CR13) 2021; 19
HR Nehara (6625_CR22) 2021; 39
6625_CR30
JB Buil (6625_CR44) 2021; 26
M Karimi-Galougahi (6625_CR26) 2021; 1
References_xml – volume: 69
  start-page: 1627
  issue: 6
  year: 2021
  ident: 6625_CR23
  publication-title: Indian J Ophthalmol
  doi: 10.4103/ijo.IJO_1053_21
– volume: 6
  start-page: 1369
  issue: 5
  year: 2021
  ident: 6625_CR53
  publication-title: J Glob Sci Res
– volume: 135
  start-page: 442
  issue: 5
  year: 2021
  ident: 6625_CR17
  publication-title: J Laryngol Otol
  doi: 10.1017/S0022215121000992
– ident: 6625_CR55
– volume: 89
  start-page: e13652
  year: 2021
  ident: 6625_CR47
  publication-title: Transpl Infect Dis
  doi: 10.1111/tid.13652
– volume: 14
  start-page: 423
  issue: 4
  year: 2012
  ident: 6625_CR4
  publication-title: Curr Infect Dis Rep
  doi: 10.1007/s11908-012-0272-6
– volume: 7
  start-page: 867
  issue: 5
  year: 2021
  ident: 6625_CR19
  publication-title: Int J Otorhinolaryngol Head Neck Surg
  doi: 10.18203/issn.2454-5929.ijohns20211583
– volume: 8
  start-page: 1
  year: 2021
  ident: 6625_CR34
  publication-title: Front Medicine
  doi: 10.3389/fmed.2021.645270
– volume: 1
  start-page: 1
  year: 2021
  ident: 6625_CR35
  publication-title: Orbit
– ident: 6625_CR57
  doi: 10.21203/rs.3.rs-533347/v1
– volume: 26
  start-page: 2100510
  issue: 23
  year: 2021
  ident: 6625_CR44
  publication-title: Eurosurveillance
  doi: 10.2807/1560-7917.ES.2021.26.23.2100510
– volume: 69
  start-page: 1002
  issue: 4
  year: 2021
  ident: 6625_CR16
  publication-title: Indian J Ophthalmol
  doi: 10.4103/ijo.IJO_3763_20
– volume: 73
  start-page: 1
  year: 2021
  ident: 6625_CR14
  publication-title: J Maxillofac Oral Surg
– volume: 23
  start-page: e01172
  year: 2021
  ident: 6625_CR45
  publication-title: IDCases
  doi: 10.1016/j.idcr.2021.e01172
– volume: 7
  start-page: 88
  issue: 2
  year: 2021
  ident: 6625_CR49
  publication-title: J Fungi
  doi: 10.3390/jof7020088
– volume: 1
  start-page: 1029
  year: 2021
  ident: 6625_CR26
  publication-title: Int Forum Allergy Rhinol
  doi: 10.1002/alr.22785
– volume: 1
  start-page: 1
  year: 2021
  ident: 6625_CR32
  publication-title: Jpn J Ophthalmol
– volume: 19
  start-page: e405
  issue: 12
  year: 2019
  ident: 6625_CR5
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(19)30312-3
– volume: 187
  start-page: 101125
  year: 2021
  ident: 6625_CR42
  publication-title: J Med Mycol
  doi: 10.1016/j.mycmed.2021.101125
– volume: 13
  start-page: 11
  issue: 1
  year: 2019
  ident: 6625_CR10
  publication-title: Current Fungal Infection Reports
  doi: 10.1007/s12281-019-0337-1
– volume: 42
  start-page: e265
  issue: 264
  year: 2021
  ident: 6625_CR36
  publication-title: Am J Emerg Med
– year: 2021
  ident: 6625_CR33
  publication-title: J Neuroradiol
  doi: 10.1016/j.neurad.2021.05.007
– ident: 6625_CR50
  doi: 10.1016/j.idnow.2021.01.010
– volume: 47
  start-page: 994
  issue: 7
  year: 2018
  ident: 6625_CR6
  publication-title: Iran J Public Health
– volume: 38
  start-page: 193
  issue: 3
  year: 2012
  ident: 6625_CR54
  publication-title: Diab Metab
  doi: 10.1016/j.diabet.2012.01.002
– volume: 39
  start-page: 380
  issue: 3
  year: 2021
  ident: 6625_CR22
  publication-title: Indian J Med Microbiol
  doi: 10.1016/j.ijmmb.2021.05.009
– ident: 6625_CR27
  doi: 10.1111/myc.13256
– volume: 69
  start-page: 244
  issue: 2
  year: 2021
  ident: 6625_CR15
  publication-title: Indian J Ophthalmol
  doi: 10.4103/ijo.IJO_3774_20
– volume: 13
  start-page: 1
  issue: 2
  year: 2021
  ident: 6625_CR51
  publication-title: Cureus
– volume: 15
  start-page: 2378
  issue: 11
  year: 2020
  ident: 6625_CR37
  publication-title: Radiol Case Rep
  doi: 10.1016/j.radcr.2020.09.026
– volume: 32
  start-page: 64
  year: 2021
  ident: 6625_CR40
  publication-title: Med Mycol
– volume: 6
  start-page: 265
  issue: 4
  year: 2020
  ident: 6625_CR11
  publication-title: J Fungi
  doi: 10.3390/jof6040265
– volume: 7
  start-page: 2027
  issue: 3
  year: 2020
  ident: 6625_CR43
  publication-title: Arch Clin Cases
  doi: 10.22551/2020.28.0703.10172
– volume: 82
  start-page: 105957
  year: 2021
  ident: 6625_CR21
  publication-title: Int J Surg Case Rep
  doi: 10.1016/j.ijscr.2021.105957
– ident: 6625_CR28
  doi: 10.21203/rs.3.rs-398594/v2
– volume: 1
  start-page: e245
  issue: 6
  year: 2020
  ident: 6625_CR46
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(20)30115-4
– ident: 6625_CR30
  doi: 10.1111/myc.13334
– volume: 12
  start-page: 386
  year: 2021
  ident: 6625_CR31
  publication-title: J Bacteriol Parasitol
– volume: 33
  start-page: 349
  issue: 2
  year: 2000
  ident: 6625_CR9
  publication-title: Otolaryngol Clin N Am
  doi: 10.1016/S0030-6665(00)80010-9
– ident: 6625_CR25
– volume: 213
  start-page: 54
  issue: 2
  year: 2020
  ident: 6625_CR1
  publication-title: Med J Aust
  doi: 10.5694/mja2.50674
– volume: 12
  start-page: 85
  issue: 3
  year: 2021
  ident: 6625_CR39
  publication-title: J Med Cases
  doi: 10.14740/jmc3637
– volume: 27
  start-page: 9
  issue: 1
  year: 2021
  ident: 6625_CR56
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2020.09.025
– year: 2021
  ident: 6625_CR2
  publication-title: Am J Emerg Med
  doi: 10.1016/j.ajem.2021.01.074
– volume: 14
  start-page: e241663
  issue: 4
  year: 2021
  ident: 6625_CR18
  publication-title: BMJ Case Rep
  doi: 10.1136/bcr-2021-241663
– volume: 26
  start-page: 944
  issue: 7
  year: 2020
  ident: 6625_CR58
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2019.11.021
– volume: 37
  start-page: e40
  issue: 2
  year: 2021
  ident: 6625_CR38
  publication-title: Ophthal Plast Reconstr Surg
  doi: 10.1097/IOP.0000000000001889
– ident: 6625_CR29
  doi: 10.1177/11206721211009450
– volume: 127
  start-page: 22
  issue: 1
  year: 2002
  ident: 6625_CR8
  publication-title: Otolaryngol Head Neck Surg
  doi: 10.1067/mhn.2002.126587
– volume: 27
  start-page: 147
  issue: 1
  year: 2021
  ident: 6625_CR3
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2020.07.047
– volume: 54
  start-page: S23
  year: 2012
  ident: 6625_CR7
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cir866
– volume: 12
  start-page: 1
  issue: 9
  year: 2020
  ident: 6625_CR12
  publication-title: Cureus
– volume: 7
  start-page: 174
  issue: 3
  year: 2021
  ident: 6625_CR41
  publication-title: J Fungi
  doi: 10.3390/jof7030174
– volume: 53
  start-page: 746
  issue: 6
  year: 2020
  ident: 6625_CR48
  publication-title: Clin Endosc
  doi: 10.5946/ce.2020.180
– ident: 6625_CR20
  doi: 10.1007/s12070-021-02574-0
– volume: 16
  start-page: 1
  year: 2020
  ident: 6625_CR52
  publication-title: Infection
– volume: 19
  start-page: 1
  year: 2021
  ident: 6625_CR13
  publication-title: Mycopathologia
– volume: 2021
  start-page: e13663
  year: 2021
  ident: 6625_CR24
  publication-title: Transpl Infect Dis
  doi: 10.1111/tid.13663
SSID ssj0017829
Score 2.4069538
SecondaryResourceType review_article
Snippet COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed rhino-facial...
Background COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who developed...
Abstract Background COVID-19 disease may be associated with a wide range of bacterial and fungal infections. We report a patient with COVID-19 infection who...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 906
SubjectTerms Biopsy
Case Report
Case reports
Case studies
Complications and side effects
Coronaviruses
Corticoids
Corticosteroids
COVID-19
Debridement
Diabetes
Diabetes Mellitus
Disease
Dosage and administration
Fungal infections
Fungi
Health services
Humans
Hyphae
Infections
Infectious diseases
Invasive Fungal Infections - diagnosis
Invasive Fungal Infections - drug therapy
Laboratories
Literature reviews
Lungs
Male
Methylprednisolone
Middle Aged
Mortality
Mucormycosis
Mucormycosis - diagnosis
Mucormycosis - drug therapy
Mycology
Oxygen saturation
Patient outcomes
Patients
Physicians
Polymerase chain reaction
Respiratory distress syndrome
Rhizopus oryzae
Risk factors
SARS-CoV-2
Septum
Sinuses
Steroids
Viral diseases
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4s1CQQYhcUBW48RObG5LoWqRSiWgVW-W4weN1CZVszn0H_RnM5Nkw0YIuHBdT6LszHhmPnv8mZA3PHoVvMwYsqczob1mNkjJohQxuCJTTuNB4cMv-f6x-HwqTzeu-sKesIEeeFDcjhdl4DpqD4lSQG5RFoFUkFwlpUrSgNEXct4aTI37B5D39PqIjMp3WojChWbYjoCM55JlszTUs_X_HpM3ktK8YXIjA-3dI3fH0pEuh0--T26F-gG5fThujj8kN0vqICfRYRuANpFenVV1w6LFZXF60QHQvLh2TVu1tKqppYD82bD2Wjk6EqxSXJilu0cnBx8Z1-9B6hfXMx3OueCbzyc2ZmprT93A8kS7S1xAeESO9z59391n40ULzOUZXzFXxqCCcqXPQd3ScVm6aH2RFbZEhAhW5mkRMyGTEGKAGhDG09xaQIcyDWn2mGzBJ4enhEbpSuWFS-FNAmKX9donBSB2mwjhQ74gfK1340YWcrwM49z0aETlZrCVAVuZ3lYmW5B30zOXAwfHX6U_oDknSeTP7n8ArzKjV5l_edWCvEZnMMiQUWMLzg_bta05ODoxS4BYUIZC6fknoW9fZ0JvR6HYwB91djz2AOpC5q2Z5PZMEua5mw-vHdOMcaY1EHBBzVwrviCvpmF8Envn6tB0KJNr3O3NQebJ4MeTcpDvUQNGXpBi5uEz7c1H6uqsZyFXCP21fPY_1P2c3En7yQlzNNsmW6urLryAYm9Vvuzn9U-ErlAl
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4t1AQQYhcUBWN4md2FzQUqhapFIJaLU3y_GjXalNls3ugX_Az2Ym8aaNEL3G4yjxvMfjz4S8TYOT3omcIXo648opZrwQLAgevC1zaRUeFD76Vhyc8K8zMYsFtza2VW5sYmeoXWOxRr4LosXBkCqZflz8YnhrFO6uxis0bpM7CF2GUl3OhoQrBe-nNgdlZLHbgi0uFcOmBMQ9FywfOaMOs_9fy3zNNY3bJq_5of0H5H4MIOm05_hDcsvXj8jdo7hF_pj8mVILnon2mwG0CXR5Pq8bFgwWx-nlGtLNy9-2aectndfUUMj_WV-BnVsaYVYplmfp3vHp4WeWqg9AdYX4TPvTLvjmiwGTmZraUdtjPdH1AssIT8jJ_pefewcsXrfAbJGnK2ar4KWXtnKF45WwqahsMK7MS1Nhngi8TrMy5FxMvA8eIkEYzwpjIEcUmc_yp2QLPtlvExqEraTjNoM3cbBgxik3KSFvNxPOnS8Skm7WXduIRY5XYlzoLieRhe55pYFXuuOVzhPyfpiz6JE4bqT-hOwcKBFFu3vQLM90VEoNv-lTFZSDIIxD3CINJulepHJSyUnmE_IGhUEjTkaNjThnZt22-vD4VE8h0YJgFALQ_xH9-D4ieheJQgM_ak08_ADLhfhbI8qdESVoux0PbwRTR2vT6ivdSMjrYRhnYgdd7Zs10hQK93wLoHnWy_GwOIj6qCBTTkg5kvDR6o1H6vl5h0UusQCgxPObP-sFuZd1agfal--QrdVy7V9CMLeqXnUa-xer1Uip
  priority: 102
  providerName: ProQuest
Title A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update
URI https://www.ncbi.nlm.nih.gov/pubmed/34479495
https://www.proquest.com/docview/2574471981
https://www.proquest.com/docview/2569382361
https://pubmed.ncbi.nlm.nih.gov/PMC8415695
https://doaj.org/article/d4be19f9d84648538a0274e5180b802e
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZ2kaa9IO4URmUQEg_I0CR2YiMh1JZNG1I3VOg08WI5jrNV6pLRtBL7B_xszsmla8TggZc81MdRc3zutr9DyCsvTaRLRMAQPZ1xlShmnBAsFTx1NgqkVXhReHQcHk745zNxtkGadkc1A4tbUzvsJzWZz97-_HH9ERT-Q6nwMnxXgI2NFMPDBohnLliwSbbBM0XY0WDEb3YVwBuq5uLMrfN2yQ4i4CmO7SbW_FQJ5_-n0V7zWu0TlWsu6uAuuVPHlrRfCcM9suGy-2RnVO-ePyC_-tSC06LVPgHNUzq_mGY5Sw3WzenlEjLRy2ubF9OCTjNqaJZnrCrOTi2tEVgpVm7p8OT06BPz1HugugGDptVFGHzzbAXXTE2WUFvBQNHlFVYYHpLJwf634SGrOzEwGwbegtk4ddJJGydhwmNhPRHb1CRREJkYU0gQA8-P0oCLnnOpgyARxv3QGEgfhe_84BHZgr_snhCaChvLhFsf3sTBuJlEJb0IUnrT4zxxYYd4Dd-1rWHKsVvGTJfpigx1tWwalk2Xy6aDDnmzmnNVgXT8k3qAy7miRIDt8od8fq5rfdXwmc5TqUogPuMQ0kiD-bsTnuzFsue7DnmJwqARQiPDMzrnZlkU-ujkVPchB4M4FWLTvxF9HbeIXtdEaQ4fak19LwLYhdBcLcq9FiUYAtsebgRTN3qkwSIDmz0lvQ55sRrGmXi4LnP5EmlChdvBIdA8ruR4xZxGHTokakl4i3vtkWx6UcKUS6wNKPH0v2c-I7t-qZygo8Ee2VrMl-45hICLuEs2o7MInnLodcn2YP_4y7hbllO6pcbDczz4_hvF2F6C
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELemIQEviP8UBhgE4gFZaxI7sZEQKh3TytZNgm3am3FsZ6u0JaVphfYN-DR8Ru6SNFuE2Nte40sU-873z3c_E_ImyJz0TkQM0dMZV04x44VgmeCZt0kkrcJG4fFuvHXAvx6JoxXyZ9kLg2WVS51YKWpXWMyRr4NocVCkSgafpj8Z3hqFp6vLKzRqsdj2578gZCs_jjaAv2_DcPPL_nCLNbcKMBtHwZzZNPPSS5u62PFU2ECkNjMuiRKTYjgEUwrCJIu46HufeXB4YDyMjYFQSIQegQ5A5d_gEWxN7EwftiUlAVhbtWzMkfF6Cbo_UQyLIBBnXbCoY_yqOwL-tQSXTGG3TPOS3du8S-40Disd1BJ2j6z4_D65OW6O5B-Q3wNqwRLS-vCBFhmdnUzygmUGk_H0bAHh7dm5LcpJSSc5NTQvclZnfCeWNrCuFNPBdLh3ONpggfoAVBcI07TursEvn7YY0NTkjtoaW4ouppi2eEgOroURj8gq_LJ_QmgmbCodtyF8iYPGNE65fuLTyPQ5dz7ukWC57to22Od4BceprmIgGeuaVxp4pSte6ahH3rfvTGvkjyupPyM7W0pE7a4eFLNj3SgBDdP0gcqUA6ePg58kDSYFvAhkP5X90PfIaxQGjbgcORb-HJtFWerR3qEeQGAHzi84vP8j-v6tQ_SuIcoKmKg1TbMFLBfifXUo1zqUoF1sd3gpmLrRbqW-2Is98qodxjexYi_3xQJpYoVnzDHQPK7luF0cRJlUEJn3SNKR8M7qdUfyyUmFfS4x4aDE06t_6yW5tbU_3tE7o93tZ-R2WG1B2InRGlmdzxb-OTiS8_RFtXsp-XHd6uIvHh2H8g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+case+report+of+rhino-facial+mucormycosis+in+a+non-diabetic+patient+with+COVID-19%3A+a+systematic+review+of+literature+and+current+update&rft.jtitle=BMC+infectious+diseases&rft.au=Mohammadi%2C+Faezeh&rft.au=Badri%2C+Milad&rft.au=Safari%2C+Shapoor&rft.au=Hemmat%2C+Nima&rft.date=2021-09-03&rft.pub=BioMed+Central&rft.eissn=1471-2334&rft.volume=21&rft_id=info:doi/10.1186%2Fs12879-021-06625-3&rft_id=info%3Apmid%2F34479495&rft.externalDocID=PMC8415695
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon